Royal DSM and Sinochem Close Antibiotics JV Deal

Royal DSM, the Dutch life sciences and materials company, and Sinochem received regulatory approval for their antibiotic JV. The JV, announced last December, called for Sinochem to buy a 50% stake in DSM’s anti-infectives unit for a price of $291 million. The JV combines DSM’s expertise in anti-infective APIs with Sinochem’s experience in China marketing. The JV will be headquartered in Hong Kong. More details.... Stock Symbol: (XAMS: DSM)     Share this with colleagues: